Ondansetron HCL 4 MG tablet 500S
Ended Awarded Last action
- Contract number
- SPE2DR26F73FD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,702
Award facts
- Contract value 100% obligated
- $16,701.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Ondansetron HCL 4 mg tablets in quantities of 500 units. This firm fixed-price delivery order, valued at $16,701.86 with an ultimate completion date of December 18, 2025, was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a commonly used antiemetic medication utilized across military and federal healthcare systems for the prevention and treatment of nausea and vomiting.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a broad range of pharmaceutical products and medical commodities to support military healthcare programs, the Defense Health Agency, and other federal healthcare systems worldwide. The company's extensive portfolio of federal contracts demonstrates its established capability to meet federal procurement requirements for medications spanning multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F73FD?
SPE2DR26F73FD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F73FD worth?
The government has obligated $16,702 on SPE2DR26F73FD.
Is contract SPE2DR26F73FD an order under another contract?
Yes. SPE2DR26F73FD is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F73FD competed?
The extent of competition for SPE2DR26F73FD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award